Published in Am J Respir Crit Care Med on November 01, 1996
Effect of salbutamol on lung function and chest wall volumes at rest and during exercise in COPD. Thorax (2005) 1.58
Extracellular superoxide dismutase protects against pulmonary emphysema by attenuating oxidative fragmentation of ECM. Proc Natl Acad Sci U S A (2010) 1.44
Skeletal muscle weakness, reduced exercise tolerance, and COPD: is systemic inflammation the missing link? Thorax (2006) 1.03
Pulmonary hyperinflation and left ventricular mass: the Multi-Ethnic Study of Atherosclerosis COPD Study. Circulation (2013) 0.99
Lung deflation and oxygen pulse in COPD: results from the NETT randomized trial. Respir Med (2011) 0.96
Pathogenesis of hyperinflation in chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis (2014) 0.94
Dynamic hyperinflation is associated with a poor cardiovascular response to exercise in COPD patients. Respir Res (2011) 0.91
The effects of altered intrathoracic pressure on resting cerebral blood flow and its response to visual stimulation. Neuroimage (2012) 0.89
Hyperinflation and its management in COPD. Int J Chron Obstruct Pulmon Dis (2006) 0.84
Strategies for cardiopulmonary exercise testing of pectus excavatum patients. Clinics (Sao Paulo) (2008) 0.82
Effect of heliox on heart rate kinetics and dynamic hyperinflation during high-intensity exercise in COPD. Eur J Appl Physiol (2010) 0.82
Influence of respiratory pressure support on hemodynamics and exercise tolerance in patients with COPD. Eur J Appl Physiol (2010) 0.81
The relationship between C-reactive protein and prognostic factors in chronic obstructive pulmonary disease. Multidiscip Respir Med (2013) 0.80
Bronchodilator effect on ventilatory, pulmonary gas exchange, and heart rate kinetics during high-intensity exercise in COPD. Eur J Appl Physiol (2009) 0.80
The Impact of Homogeneous Versus Heterogeneous Emphysema on Dynamic Hyperinflation in Patients With Severe COPD Assessed for Lung Volume Reduction. COPD (2015) 0.79
Mechanisms of dyspnea in healthy subjects. Multidiscip Respir Med (2010) 0.79
Cardiovascular and respiratory dysfunction in chronic obstructive pulmonary disease complicated by impaired peripheral oxygenation. Int J Chron Obstruct Pulmon Dis (2015) 0.77
The effect of pulmonary hypertension on aerobic exercise capacity in lung transplant candidates with advanced emphysema. Lung (2015) 0.77
Venous admixture in COPD: pathophysiology and therapeutic approaches. COPD (2008) 0.77
Exercise dyspnea in patients with COPD. Int J Chron Obstruct Pulmon Dis (2007) 0.75
Advances in the Evaluation of Respiratory Pathophysiology during Exercise in Chronic Lung Diseases. Front Physiol (2017) 0.75
Systemic manifestations and comorbidities of COPD. Eur Respir J (2009) 5.90
Outcomes for COPD pharmacological trials: from lung function to biomarkers. Eur Respir J (2008) 5.38
C-reactive protein in patients with COPD, control smokers and non-smokers. Thorax (2005) 2.72
Nosocomial pneumonia in intubated patients given sucralfate as compared with antacids or histamine type 2 blockers. The role of gastric colonization. N Engl J Med (1987) 2.64
The 6-min walk distance: change over time and value as a predictor of survival in severe COPD. Eur Respir J (2004) 2.63
C-reactive protein levels and clinically important predictive outcomes in stable COPD patients. Eur Respir J (2006) 2.33
Pulmonary rehabilitation and the BODE index in COPD. Eur Respir J (2005) 2.23
Validation and comparison of reference equations for the 6-min walk distance test. Eur Respir J (2007) 2.04
Long-term controlled trial of nocturnal nasal positive pressure ventilation in patients with severe COPD. Chest (2000) 1.94
The 6-min walk distance in healthy subjects: reference standards from seven countries. Eur Respir J (2010) 1.90
Sex differences in mortality in patients with COPD. Eur Respir J (2008) 1.79
Inspiratory capacity, dynamic hyperinflation, breathlessness, and exercise performance during the 6-minute-walk test in chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2001) 1.76
Circulating fibronectin to C-reactive protein ratio and mortality: a biomarker in COPD? Eur Respir J (2008) 1.76
Chronic interstitial pulmonary fibrosis produced in hamsters by endotracheal bleomycin. Lung volumes, volume-pressure relations, carbon monoxide uptake, and arterial blood gas studied. Am Rev Respir Dis (1978) 1.57
International approaches to the prescription of long-term oxygen therapy. Eur Respir J (2001) 1.57
Localized amyloidosis of the lower respiratory tract. Am Rev Respir Dis (1978) 1.54
Increased gastro-oesophageal reflux disease in patients with severe COPD. Eur Respir J (2004) 1.29
Lung-volume reduction improves dyspnea, dynamic hyperinflation, and respiratory muscle function. Am J Respir Crit Care Med (1997) 1.21
Effects of hyperinflation on the oxygen pulse as a marker of cardiac performance in COPD. Eur Respir J (2008) 1.20
Limitations of randomized clinical trials for evaluating emerging operations: the case of lung volume reduction surgery. Ann Thorac Surg (2001) 1.16
Patterns of pulmonary involvement in systemic amyloidosis. Chest (1978) 1.15
A controlled trial of intermittent positive pressure breathing, incentive spirometry, and deep breathing exercises in preventing pulmonary complications after abdominal surgery. Am Rev Respir Dis (1984) 1.15
The 6-min walking distance: long-term follow up in patients with COPD. Eur Respir J (2006) 1.09
Long-term oxygen therapy. N Engl J Med (1995) 1.02
Pneumomediastinum in a 63-year-old woman with asthma exacerbation. Chest (2000) 1.02
Improved diaphragmatic function after surgical plication for unilateral diaphragmatic paralysis. Am Rev Respir Dis (1992) 1.01
The modified BODE index: validation with mortality in COPD. Eur Respir J (2008) 0.99
Dyssynchronous breathing during arm but not leg exercise in patients with chronic airflow obstruction. N Engl J Med (1986) 0.99
Predicting complications after pulmonary resection. Preoperative exercise testing vs a multifactorial cardiopulmonary risk index. Chest (1993) 0.97
Quality and reproducibility of spirometry in COPD patients in a randomized trial (UPLIFT®). Respir Med (2013) 0.96
Ventilatory muscle recruitment during unsupported arm exercise in normal subjects. J Appl Physiol (1985) (1988) 0.96
The obesity hypoventilation syndrome can be treated with noninvasive mechanical ventilation. Chest (2001) 0.95
Hypothyroidism. A reversible cause of diaphragmatic dysfunction. Chest (1989) 0.92
Effect of unsupported arm exercise on ventilatory muscle recruitment in patients with severe chronic airflow obstruction. Am Rev Respir Dis (1988) 0.91
Factors influencing ventilatory muscle recruitment in patients with chronic airflow obstruction. Am Rev Respir Dis (1990) 0.91
Noninvasive positive pressure ventilation and not oxygen may prevent overt ventilatory failure in patients with chest wall diseases. Chest (1997) 0.90
Is pulmonary rehabilitation an effective treatment for chronic obstructive pulmonary disease? Yes. Am J Respir Crit Care Med (1997) 0.89
Respiratory response to arm elevation in patients with chronic airflow obstruction. Am Rev Respir Dis (1991) 0.89
Controlled trial of external negative pressure ventilation in patients with severe chronic airflow obstruction. Am Rev Respir Dis (1989) 0.88
Arm training reduces the VO2 and VE cost of unsupported arm exercise and elevation in chronic obstructive pulmonary disease. J Cardiopulm Rehabil (1997) 0.87
Respiratory response and ventilatory muscle recruitment during arm elevation in normal subjects. Chest (1992) 0.84
Postoperative pulmonary complications. Med Clin North Am (2001) 0.84
Ventilatory muscle dysfunction in patients with bilateral idiopathic diaphragmatic paralysis: reversal by intermittent external negative pressure ventilation. Am Rev Respir Dis (1987) 0.83
Mouth occlusion pressure, CO2 response and hypercapnia in severe chronic obstructive pulmonary disease. Eur Respir J (1998) 0.83
Pulmonary rehabilitation that includes arm exercise reduces metabolic and ventilatory requirements for simple arm elevation. Chest (1993) 0.82
Acute pneumonitis after subcutaneous injections of silicone. N Engl J Med (1983) 0.81
Weaning from mechanical ventilation. Int Anesthesiol Clin (1999) 0.81
The light at the end of the tunnel: is COPD prevalence changing? Eur Respir J (2010) 0.81
Respiratory muscle testing. Clin Chest Med (2001) 0.81
Correlations between dyspnea, diaphragm and sternomastoid recruitment during inspiratory resistance breathing in normal subjects. Chest (1990) 0.81
Respiratory muscle recruitment and exercise performance in eucapnic and hypercapnic severe chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2000) 0.80
Ventilatory drive at rest and perception of exertional dyspnea in severe COPD. Chest (1999) 0.79
Maximum expiratory flow and transpulmonary pressure in the hamster. J Appl Physiol Respir Environ Exerc Physiol (1978) 0.79
Inability to perform bicycle ergometry predicts increased morbidity and mortality after lung resection. Chest (1995) 0.78
Respiratory input impedance from 4 to 256 Hz in normals and chronic airflow obstruction: comparisons and correlations with spirometry. Am Rev Respir Dis (1992) 0.78
Ventilatory muscle recruitment in exercise with O2 in obstructed patients with mild hypoxemia. J Appl Physiol (1985) (1987) 0.78
Respiratory consequences of abdominal hernia in a patient with severe chronic obstructive pulmonary disease. Am Rev Respir Dis (1985) 0.77
Ventilatory response to arm elevation. Its determinants and use in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med (1995) 0.76
Sex, forced expiratory volume in 1 s decline, body weight change and C-reactive protein in COPD patients. Eur Respir J (2009) 0.75
Factors determining the pattern of ventilatory muscle recruitment (VMR) in patients with chronic obstructive pulmonary disease (COPD). Chest (1990) 0.75
Preventing PPC. Chest (1985) 0.75
[Peripheral muscles in COPD: deconditioning or myopathy?]. Arch Bronconeumol (2001) 0.75
Cardiopulmonary exercise testing in patients with chronic obstructive pulmonary disease. Cleve Clin J Med (1993) 0.75
Arm exercise and ventilation. Chest (1988) 0.75
[Cardiopulmonary exertion test in patients with chronic obstructive pulmonary disease (COPD)]. Arch Bronconeumol (1997) 0.75
Bilateral diaphragm paralysis secondary to central von Recklinghausen's disease. Chest (2000) 0.75
Nonresolving spontaneous pneumothorax in a 38-year-old woman. Chest (1996) 0.75
Beta-agonists and death from asthma. N Engl J Med (1992) 0.75
Four-year-old boy with small right lung? . . . or . . . large left lung? Clin Notes Respir Dis (1983) 0.75
Special considerations in the elderly patient. Clin Chest Med (1993) 0.75
Use of transfer impedance measurements for clinical assessment of lung mechanics. Am J Respir Crit Care Med (1998) 0.75
Respiratory muscle function. Clin Chest Med (1986) 0.75
[Progress of respiratory muscle dysfunction in patients with severe chronic obstructive disease]. Arch Bronconeumol (1997) 0.75